Effect of Female Age on Infertility Diagnostic Factors and In-vitro Fertilization Treatment Outcomes: A Single-center Retrospective Cohort Study

Zhouxuan Li, Songyuan Tang, Shan Liu, Huan Xu, Zhen Lei, Ying ZhongmedRxiv 2021 · DOI

Abstract

Advanced maternal age (AMA) is a primary driver of infertility worldwide. This retrospective cohort study analyzed 45,743 fresh, autologous IVF cycles at a single high-volume center in China to quantify how diagnostic factors and clinical outcomes deteriorate with age. Results show significant increases in cycle cancellation rates and FSH levels alongside sharp declines in ovarian reserve markers (AFC, AMH) and live birth rates. Notably, the economic cost to achieve a single live birth increases nearly 40-fold for women over 45 compared to those under 35, highlighting a dramatic "economic cliff" in fertility treatment.

Introduction

As social and economic shifts lead more women to postpone childbirth, Advanced Maternal Age (AMA)—typically defined as 35 or older—has become a primary hurdle in reproductive medicine. In China, the transition from the one-child to the two-child policy has further increased the number of older women seeking In-vitro Fertilization (IVF). While the general decline in fertility with age is well-documented, many studies lack granular data on women in their 40s. This research provides a high-resolution look at how specific diagnostic markers and treatment outcomes shift year-by-year as women age.

Methods

The study utilized a massive real-world dataset of 45,743 fresh, autologous IVF cycles performed between January 2008 and September 2017 at the Jinjiang District Maternal and Child Health Hospital in Chengdu, China. Researchers stratified patients into three primary groups (<35, 35-41, and ≥42) and further subdivided the oldest cohort into single-year increments (42, 43, 44, and ≥45) to capture the rapid decline in reproductive viability. Key variables included ovarian reserve markers (Basic FSH, AFC, and AMH), cycle metrics (oocytes retrieved, fertilization rates), and clinical outcomes (pregnancy and live birth rates).

Results

The Ovarian Reserve "Fade" and Cancellation Trap

Diagnostic markers showed a clear, statistically significant deterioration with advancing age. Basic Follicle Stimulating Hormone (FSH) levels increased, while Antral Follicle Count (AFC) and Anti-Müllerian Hormone (AMH) plummeted. By age 44, the average AFC dropped to approximately 3, indicating a severely diminished egg supply.

Baseline characteristics and diagnostic markers across age groups.

One of the most significant findings was the cycle cancellation rate. For women under 35, approximately 39.4% of cycles were cancelled, often due to poor response to stimulation. For women ≥42, this jumped to 85.03%, and for those over 44, it reached 91.15%. This means the vast majority of older patients never reach the embryo transfer stage.

Clinical and Economic Outcomes

It wasn't just that older women produced fewer eggs; the eggs produced were less likely to result in a live birth. The mean number of retrieved oocytes dropped from 12.15 in the youngest group to just 2.95 in the ≥42 group. Consequently, live birth rates per cycle dropped from 34.52% in the youngest group to 7.06% at age 42, and essentially 0% for women aged 45 and 46 in this dataset.

While the cost of a single cycle actually decreases with age (because cycles are often cancelled early before expensive procedures occur), the cost per live birth explodes.

Comparison of IVF cycle costs and the cost per live birth by age.

The mean cost to achieve one live birth was approximately 33,514 RMB for women under 35. For women ≥45, that estimated cost soared to 1,357,154 RMB—a prohibitive sum for the average family.

Discussion and Conclusion

This study highlights that while IVF technology has advanced, it cannot fully compensate for the biological decline of the ovarian reserve. The "economic cliff" observed in women over 42 suggests a critical need for better counseling regarding realistic expectations and the importance of seeking treatment earlier.

Limitations include the retrospective nature of the study and the simplified economic analysis which did not account for varying stimulation protocols. Future research should integrate more detailed medication cost data and compare these Chinese outcomes with international datasets to refine global guidance for AMA patients.

Summary updated

Abstract

Abstract Background Infertility has become an important issue in modern world because of the increasing number of infertile couples around the world. Advanced maternal age was considered to be a main factor of infertile problem. With second child policy published in China and more women in China intend to seek help for infertility problem, this study provided information of fertility diagnostic factors and IVF treatment outcomes of female IVF patients in different age groups, which can be a guidance for infertility diagnostic and treatment. Methods A retrospective cohort study was conducted to IVF patient data collected by Jinjiang District Maternal and Child Health Hospital, Chengdu, China. Clinical and laboratory data of 45,743 fresh, autologous IVF cycles from January 2008 to September 2017 were included in the analysis. The diagnostic factors and treatment outcomes were analyzed for different age groups (age&lt;35, n=30,708; age 35-41, n=11,921 and age≥42, n=3,114) as well as further stratified advanced age groups (age 42, n=933; age 43, n=744; age 44, n=556; age≥45, n=881). The characteristics including number of previous cycles, duration of infertility, BMI, basic FSH, basic AFC, AMH, retrieved oocyte number, fertilized oocyte number, transferred embryo number, baby number and economic cost were stratified according to patient age. Results The basic characteristics of obesity rate, basic FSH and cancellation rate of IVF cycles in ≥42 years old group were significantly higher than other groups (p&lt;0.01). Basic AFC, AMH, retrieved oocyte number, fertilized oocyte number and transferred embryo number in ≥42 years old group were significantly lower than other groups (p&lt;0.01). Diagnostics characteristics and IVF-ET outcome declined significantly when maternal age increased (p&lt;0.05). In the meanwhile, a preliminary analysis of cost per cycle showed that cost per child increased with patient’s age increase. Conclusion Although with increasing number of advanced maternal age IVF cycles, the age group of ≥42 years would intend to get unsatisfied outcome and higher cost per child. More guidance and considerations should be focused on encouraging earlier age treatment of infertility. Plain English summary With more and more women in the global range choose to get late pregnancy because of changes in society and economy, age has become an unavoidable factor in infertility diagnostic and treatment. Advanced age women may experience more infertility problems and negative IVF outcomes. A better understanding of the effect of maternal age on infertility would offer help to both diagnostic and treatment of IVF patient. This study conducted a single-center retrospective cohort analysis to female patients of different age groups and found that women with more advanced age (≥42) would be more easily to experience unsatisfied IVF outcome and higher economic cost to obtain one child. After the publication of second child policy in China in 2013, the number of advanced age patients increased, the necessity of special guidance for AMA patient may need to be taken into consideration.
BibTeX
@misc{li2021effect,
  author = {Zhouxuan Li and Songyuan Tang and Shan Liu and Huan Xu and Zhen Lei and Ying Zhong},
  title = {{Effect of Female Age on Infertility Diagnostic Factors and In-vitro Fertilization Treatment Outcomes: A Single-center Retrospective Cohort Study}},
  year = {2021},
  doi = {10.1101/2021.01.04.21249246},
  howpublished = {medRxiv},
}
Figure